Publications

Nonimmediate drug allergy: diagnostic benefit of skin testing and practical approach

Schnyder B, Pichler WJ

The Journal of allergy and clinical immunology,  1 Avr 2012


KRAS mutation testing in colorectal cancer: comparison of the results obtained using 3 different methods for the analysis of codons G12 and G13

Bihl MP, Hoeller S, Andreozzi MC, Foerster A, Rufle A, Tornillo L, Terracciano L

Diagnostic molecular pathology : the American journal of surgical pathology, part B,  31 Mar 2012


HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma

Piscuoglio S, Zlobec I, Pallante P, Sepe R, Exposito F, Zimmermann A, Diamantis I, Terracciano L, Fusco A, Karamitopoulou E

Histopathology,  1 Fév 2012


Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater

Piscuoglio S, Lehmann FS, Zlobec I, Tornillo L, Dietmaier W, Hartmann A, Wünsch PH, Sessa F, Rümmele P, Baumhoer D, Terracciano LM

Journal of clinical pathology,  1 Fév 2012


The anabolic androgenic steroid fluoxymesterone inhibits 11β-hydroxysteroid dehydrogenase 2-dependent glucocorticoid inactivation.

Fürstenberger C, Vuorinen A, Da Cunha T, Kratschmar DV, Saugy M, Schuster D, Odermatt A

Toxicological sciences : an official journal of the Society of Toxicology,  26 Jan 2012


Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spot.

Daali Y, Samer C, Déglon J, Thomas A, Chabert J, Rebsamen M, Staub C, Dayer P, Desmeules J

Clinical pharmacology and therapeutics,  13 Jan 2012


LC-MS (/MS) in clinical toxicology screening methods

Viette V, Hochstrasser D, Fathi M

Chimia,  1 Jan 2012


Sample Preparation of Urine Samples Prior to CE-MS in Toxicological Analysis

Rovini M, Schappler J, Kohler I, Anzini M, Veuthey JL, Rudaz S

Journal of Chemistry and Chemical Engineering,  31 Déc 2011


Post genomic decade--the epigenome and exposome challenges

Paoloni-Giacobino A

Swiss Medical Weekly,  19 Déc 2011


Ebselen is a new skin depigmenting agent that inhibits melanin biosynthesis and melanosomal transfer.

Kasraee B, Nikolic DS, Salomon D, Carraux P, Fontao L, Piguet V, Omrani GR, Sorg O, Saurat JH

Experimental dermatology,  16 Nov 2011